Nurix

Senior Scientist, Antibody Conjugation

Nurix$155K — $180K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD in chemistry, biochemistry, chemical biology, or related field preferred; MS or BS with substantial hands-on industry bioconjugation experience accepted.
  • Direct experience with antibody/protein bioconjugation chemistry (e.g., NHS ester coupling, click chemistry).
  • Expertise in purifying and characterizing conjugates using various chromatography methods.
  • Familiarity with preparing protocols for automated execution; willingness to learn automation in collaboration with the team is a plus.
  • Proven track record of practical problem-solving in the lab.

Responsibilities

  • Develop and optimize bioconjugation methods for antibody payloads and linkers.
  • Design conjugation protocols suitable for automation with clear process parameters.
  • Execute scale-up conjugation runs for material production to meet study timelines.
  • Purify conjugates and troubleshoot issues related to yield and stability.
  • Compose clear SOPs and technical reports; train automation colleagues in workflows.
  • Collaborate with cross-functional teams to align on linker and payload design.
  • Keep up to date on bioconjugation methodologies relevant to Nurix's pipeline.

Benefits

  • Direct involvement in creating a new technical capability within an established organization.
  • Opportunity for autonomy in a growing technical area.
  • Exposure to leadership and fast-track from development to studies.
  • Highly collaborative work environment.
Full Job Description
About the Role

We are growing the team with a hands-on antibody conjugation scientist who will build this capability from the ground up by developing and validating bioconjugation chemistries that are reproducible at bench scale, sufficiently robust for transfer to automated higher-throughput synthesis workflows, and scalable for preparation campaigns supporting advanced in vivo and translational studies.

This is a lab-based role for someone who wants to build a new technical capability inside an established, highly collaborative discovery organization and partner closely with medicinal chemistry, analytical chemistry, computational chemistry, protein biochemistry, and automation to move candidates from bench to study-ready material.
What You'll Do
  • Develop and optimize antibody bioconjugation methods for attaching degrader payloads and linkers to antibodies.
  • Design conjugation chemistry with an eye toward automation: define protocols, reagent ratios, and process parameters in a form that can be transferred to and run reliably on liquid-handling platforms.
  • Execute one-off and scale-up conjugation runs (mg to multi-mg) to produce material for pharmacology, PK/PD, and other advanced studies on program timelines.
  • Purify conjugates via FPLC/AKTA, TFF, and column chromatography; troubleshoot yield, homogeneity, and stability issues as they arise.
  • Write clear SOPs and technical reports; train and support automation-team colleagues in executing conjugation workflows independently.
  • Collaborate cross-functionally with medicinal chemists (linker/payload design), computational chemists (site selection, modeling), and external CROs/CDMOs as needed.
  • Stay current on emerging bioconjugation and DAC/ADC methodology and bring forward new techniques relevant to Nurix's pipeline.
Who You Are
  • A team player who works well across disciplines (chemistry, analytical, protein biochemistry, automation/engineering) and communicates clearly with both scientists and technical staff.
  • Results-oriented: you drive a method from first attempt to a robust, transferable protocol, and you personally deliver material when a study needs it.
  • Comfortable owning a technical area with real autonomy in a growing capability area.
Qualifications
  • PhD in chemistry, biochemistry, chemical biology, or a related field preferred; MS or BS with substantial (8+ for BS/MS) hands-on industry bioconjugation experience will also be considered.
  • Direct, hands-on experience with antibody/protein bioconjugation chemistry: NHS ester and maleimide coupling, click chemistry (CuAAC/SPAAC/IEDDA), engineered-cysteine or glycan/enzymatic site-specific conjugation, or unnatural-amino-acid approaches.
  • Experience purifying and characterizing conjugates: FPLC/AKTA, TFF, SEC, IEX, RP-HPLC/UPLC, HIC, and LC-MS-based DAR/identity analysis.
  • Experience preparing protocols for automated or semi-automated execution (e.g., liquid handlers such as Hamilton or Tecan) is a strong plus, though the successful candidate may also learn this in partnership with our automation team.
  • Strong record of practical problem-solving in the lab, with the judgment to know when a result is study-ready versus needs more optimization
Why This Role

You'll be the founding technical expert for antibody conjugation at Nurix, shaping both the science and how it's automated and scaled - with direct visibility to program leadership and a fast path from method development to real studies

Salary Range: 155K - 180K plus bonus and equity

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Senior Scientist, Antibody Conjugation jobs: